<\/span><\/h2>\r\n\r\n\r\n\r\nUnitedHealthcare, the insurance arm of UnitedHealth Group, delivered solid results in Q3 2024, contributing significantly to the group’s overall performance.<\/p>\r\n\r\n\r\n\r\n
Revenue and Membership<\/strong><\/p>\r\n\r\n\r\n\r\nUnitedHealthcare reported total revenues of $74.9 billion in Q3, a 7.2% increase year over year. This growth was supported by a strong domestic membership base, which reached 49.3 million. The company continues to expand its reach across various segments:<\/p>\r\n
\r\n- Commercial membership stood at 29.7 million.<\/li>\r\n
- Medicaid membership reached 7.5 million.<\/li>\r\n
- Medicare Advantage membership totaled 7.8 million.<\/li>\r\n
- Medicare Supplement plans cover 4.3 million individuals.<\/li>\r\n
- Medicare Part D plans had 3.1 million members.<\/li>\r\n<\/ul>\r\n\r\n\r\n\r\n
This diverse membership base enables UnitedHealthcare to generate steady revenue from multiple streams, ensuring long-term growth.<\/p>\r\n\r\n\r\n\r\n
Medical Loss Ratio and Operating Margins<\/strong><\/p>\r\n\r\n\r\n\r\nThe medical loss ratio (MLR), a key metric in healthcare insurance that measures the percentage of premium revenues spent on medical claims, increased to 85.2% in Q3 2024 compared to 82.3% in the same quarter last year. Despite this increase, UnitedHealthcare managed to maintain strong operating income of $4.2 billion with a 5.6% operating margin.<\/p>\r\n\r\n\r\n\r\n
Days claims payable, another important measure of financial health, decreased to 47.4 days in Q3 2024 from 50.7 days in Q3 2023, indicating improved efficiency in claims management.<\/p>\r\n\r\n\r\n\r\n
<\/span>Optum’s Contribution to Q3 2024 Results<\/span><\/h2>\r\n\r\n\r\n\r\nOptum, UnitedHealth Group\u2019s health services division, continues to be a strong growth driver for the company. Optum’s diverse operations, spanning health services, pharmacy care services, and data analytics, make it a significant contributor to the group’s overall success.<\/p>\r\n\r\n\r\n\r\n
Optum Health, Optum Rx, and Optum Insights<\/strong><\/p>\r\n\r\n\r\n\r\nIn Q3 2024, Optum reported total revenues of $63.9 billion, representing a 12.7% year-over-year increase. This growth was primarily led by Optum Health and Optum Rx.<\/p>\r\n\r\n\r\n\r\n